Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
April 26, 2018
Vermillion Announces Recognition by and Publication in Two Top Physician Educational Resources
AUSTIN, Texas, April 26, 2018 (GLOBE NEWSWIRE) -- ASPiRA LABs, a Vermillion company (VRML), today announced that two top physician educational resources, UpToDate and the ...
April 26, 2018
Rexahn to Present Clinical Data at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
ROCKVILLE, Md., April 26, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical-stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of ...
April 26, 2018
Krystal Biotech Announces FDA Clearance of IND on KB103 to Begin Enrolling Patients for the Treatment of Dystrophic Epidermolysis Bullosa
PITTSBURGH, April 26, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., ("Krystal") (KRYS), a gene therapy company developing topical and intradermal "off-the-shelf" treatments for rare dermatological ...
April 26, 2018
Achaogen Wins CARB-X Funding Award to Advance Development of Novel Aminoglycoside to Fight Highly-Resistant Infections
SOUTH SAN FRANCISCO, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
April 26, 2018
PolarityTE Leadership to Participate in the Symposium on Advanced Wound Care
SALT LAKE CITY, April 26, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL) today announced attendance and participation in the Symposium on Advanced Wound Care Spring ...
April 26, 2018
Minerva Neurosciences to Report First Quarter 2018 Financial Results and Business Updates on May 3, 2018
WALTHAM, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
April 26, 2018
Transgene: €35.6 Million in Cash and Cash Equivalents as of March 31, 2018
STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (TNG.PA) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies against cancers and infectious diseases, today announces its ...
April 26, 2018
AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants
NEW YORK, April 26, 2018 (GLOBE NEWSWIRE) --  AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ...
April 25, 2018
Conatus Pharmaceuticals to Report First Quarter 2018 Financial Results
SAN DIEGO, April 25, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (CNAT) today announced that it will report financial results for the first quarter ended ...
April 25, 2018
ARMO BioSciences Announces Poster Presentations of Pegilodecakin (AM0010) at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
REDWOOD CITY, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- ARMO BioSciences, Inc. (ARMO), a late-stage immuno-oncology company, today announced three abstracts on pegilodecakin (AM0010), a ...
April 25, 2018
FDA Determines that Afrezza REMS Communication Plan Has Met Goals and REMS No Longer Necessary
WESTLAKE VILLAGE, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD), focused on the development and commercialization of inhaled therapeutic products for patients with ...
April 25, 2018
Aptose Announces Appointment of Caroline M. Loewy to Board of Directors
SAN DIEGO and TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (APTO) (APS.TO), a clinical-stage company developing highly differentiated therapeutics targeting the underlying ...
April 25, 2018
Zogenix Announces Presentation of New Efficacy and Safety Data from its First Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome
EMERYVILLE, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
April 25, 2018
PolarityTE, Inc. Regains Compliance With NASDAQ Independent Director Requirement
SALT LAKE CITY, April 25, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL) today announced it has received formal notification from the Listing Qualifications Department of ...
April 25, 2018
DURECT Announces Patient Dosing in Phase 2a Trial of DUR-928 in Alcoholic Hepatitis
CUPERTINO, Calif., April 25, 2018 /PRNewswire/ -- DURECT Corporation (DRRX) today announced it has commenced patient dosing in a Phase 2a clinical trial of DUR-928 ...
April 25, 2018
Achaogen to Host Conference Call and Webcast of First Quarter 2018 Financial Results on May 4, 2018
SOUTH SAN FRANCISCO, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
April 25, 2018
Theravance Biopharma Highlights Approval of Expanded Indication in the US for Once-Daily Trelegy Ellipta for Treatment of COPD Patients
DUBLIN, April 25, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) ("Theravance Biopharma") today highlighted that the US Food and Drug Administration (FDA) has approved an expanded ...
April 25, 2018
Onxeo S.A.: Combined General Meeting on May 16, 2018
PARIS--(BUSINESS WIRE)-- Regulatory News: Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO FR0010095596), a biotechnology company specializing in the development of innovative drugs in oncology, in particular against ...
April 24, 2018
Onxeo Announces Initiation of DRIIV Phase I Clinical Trial of AsiDNA™ for Treatment of Advanced Solid Tumor
PARIS--(BUSINESS WIRE)--Regulatory News: Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO FR0010095596), a biotechnology company specializing in the development of innovative drugs in oncology, notably against rare ...
April 24, 2018
Arrowhead Pharmaceuticals to Webcast Fiscal 2018 Second Quarter Results
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it will host a webcast and conference call on May 8, 2018, at 4:30 p.m. EDT ...
Page 47 of 117